152 related articles for article (PubMed ID: 2873695)
1. [Effect of 5-aminosalicylic acid as a constituent of sulfasalazine in the treatment of chronic polyarthritis].
Wörth WD; Müller W
Z Rheumatol; 1986; 45(2):79-82. PubMed ID: 2873695
[TBL] [Abstract][Full Text] [Related]
2. A study to determine the active moiety of sulphasalazine in rheumatoid arthritis.
Neumann VC; Taggart AJ; Le Gallez P; Astbury C; Hill J; Bird HA
J Rheumatol; 1986 Apr; 13(2):285-7. PubMed ID: 2873245
[TBL] [Abstract][Full Text] [Related]
3. Which component of sulphasalazine is active in rheumatoid arthritis?
Pullar T; Hunter JA; Capell HA
Br Med J (Clin Res Ed); 1985 May; 290(6481):1535-8. PubMed ID: 2860942
[TBL] [Abstract][Full Text] [Related]
4. 5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?
Taggart AJ; Neumann VC; Hill J; Astbury C; Le Gallez P; Dixon JS
Drugs; 1986; 32 Suppl 1():27-34. PubMed ID: 2877851
[TBL] [Abstract][Full Text] [Related]
5. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
Bird HA
Br J Rheumatol; 1995 Nov; 34 Suppl 2():16-9. PubMed ID: 8535642
[TBL] [Abstract][Full Text] [Related]
6. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
Habal FM; Greenberg GR
Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391
[TBL] [Abstract][Full Text] [Related]
7. [New salicylic acid derivatives in the treatment of inflammatory intestinal diseases].
Kovács A
Orv Hetil; 1991 Jun; 132(24):1317-21. PubMed ID: 1677465
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of stress-induced gastric ulcers by sulphasalazine and its constituents (sulphapyridine and 5-aminosalicylic acid) in rats.
Garg GP; Cho CH; Ogle CW
Pharmacology; 1990; 40(6):318-24. PubMed ID: 1978355
[TBL] [Abstract][Full Text] [Related]
9. Sulfasalazine treatment and lymphocyte function in patients with rheumatoid arthritis.
Symmons DP; Salmon M; Farr M; Bacon PA
J Rheumatol; 1988 Apr; 15(4):575-9. PubMed ID: 2899645
[TBL] [Abstract][Full Text] [Related]
10. [Aminosalicylates in chronic inflammatory intestinal diseases and rheumatoid arthritis].
Maier KP
Dtsch Med Wochenschr; 1992 Oct; 117(42):1614-5. PubMed ID: 1356747
[No Abstract] [Full Text] [Related]
11. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis.
Andreoli A; Spinella S; Levenstein S; Prantera C
Ital J Gastroenterol; 1994 Apr; 26(3):121-5. PubMed ID: 7914759
[TBL] [Abstract][Full Text] [Related]
12. Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease.
Kreisel W; Wolf LM; Grotz W; Grieshaber M
Eur J Gastroenterol Hepatol; 1996 May; 8(5):461-8. PubMed ID: 8804875
[TBL] [Abstract][Full Text] [Related]
13. Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.
van Hees PA; Bakker JH; van Tongeren JH
Gut; 1980 Jul; 21(7):632-5. PubMed ID: 6107263
[TBL] [Abstract][Full Text] [Related]
14. Sulphasalazine-induced reversible male infertility.
Delaere KP; Strijbos WE; Meuleman EJ
Acta Urol Belg; 1989; 57(1):29-33. PubMed ID: 2566274
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.
Klotz U
Clin Pharmacokinet; 1985; 10(4):285-302. PubMed ID: 2864155
[TBL] [Abstract][Full Text] [Related]
16. Sulphasalazine in the treatment of rheumatoid arthritis.
Pelísková Z; Vácha J; Trnavský K
Z Rheumatol; 1985; 44(6):263-6. PubMed ID: 2869625
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y
Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235
[TBL] [Abstract][Full Text] [Related]
18. Is the beneficial effect of sulfasalazine due to inhibition of synovial neovascularization?
Madhok R; Wijelath E; Smith J; Watson J; Sturrock RD; Capell HA
J Rheumatol; 1991 Feb; 18(2):199-202. PubMed ID: 1708829
[TBL] [Abstract][Full Text] [Related]
19. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.
Baker DE; Kane S
Rev Gastroenterol Disord; 2004; 4(2):86-91. PubMed ID: 15185719
[TBL] [Abstract][Full Text] [Related]
20. [5-ASA versus sulfasalazine].
Varela E
Acta Gastroenterol Latinoam; 1994; 25(5):317-9. PubMed ID: 7785405
[No Abstract] [Full Text] [Related]
[Next] [New Search]